Page 524 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 524

4       References


                     84. Wallentin L, Goldstein P, Armstrong PW, et al. Efficacy and     98. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril
                        safety of tenecteplase in combination with the low-molecular-  on mortality and morbidity in  patients with left ventricular
                        weight heparin enoxaparin or unfractionated heparin in the   dysfunction after myocardial infarction. Results of the Survival
                        prehospital setting: the Assessment of the Safety and Efficacy   and Ventricular Enlargement Trial.  N Engl J Med. 1992;327:
                        of a New Fibrinolytic Regimen (ASSENT)-3 PLUS random-  669-677.
                        ized trial in acute myocardial infarction. Circulation. 2003;108:     99. Edner M, Bonarjee VV, Nilsen DW, Berning J, Carstensen S,
                        135-142.                                               Caidahl  K.  Effect  of  enalapril initiated  early  after  acute
                     85. Yusuf S, Mehta SR, Chrolavicius S, et al. Effects of fondaparinux   myocardial infarction on heart failure parameters, with refer-
                        on mortality and reinfarction in patients with acute ST-segment   ence to clinical class and echocardiographic determinants.
                        elevation myocardial infarction: the OASIS-6 randomized trial.   CONSENSUS II Multi-Echo Study Group. Clin Cardiol. 1996;19:
                        JAMA. 2006;295:1519-1530.                              543-548.
                     86. Mehta  SR,  Granger  CB,  Eikelboom  JW,  et  al.  Efficacy and     100. Gibson RS, Boden WE, Theroux P, et al. Diltiazem and reinfarc-
                        safety of fondaparinux versus enoxaparin in patients with   tion in patients with non-Q-wave myocardial infarction. Results
                        acute coronary syndromes undergoing percutaneous coronary   of a double-blind, randomized, multicenter trial. N Engl J Med.
                        intervention: results from the OASIS-5 trial. J Am Coll Cariol.   1986;315:423-429.
                        2007;50:1742-1751.                                  101. MacMahon S, Collins R, Peto R, Koster RW, Yusuf S. Effects of
                     87. Gruppo Italiano per lo Studio della Sopravvinza nell’Infarto   prophylactic lidocaine in suspected acute myocardial infarction.
                        Miocardico (GISSI). GISSI-3: effects of lisinopril and transder-  An overview of results from the randomized, controlled trials.
                        mal glyceryl trinitrate singly and together on 6-week mortality   JAMA. 1988;260:1910-1916.
                        and ventricular function after acute myocardial infarction.     102. Lauler DP. Magnesium—coming of age.  Am  J  Cardiol.
                        Lancet. 1994;343:1115-1122.                            1989;63:1g-3g.
                     88. ISIS-4 (Fourth International Study of Infarct Survival) Study     103. Braunwald E. Unstable angina. A classification.  Circulation.
                        Group. ISIS-4: a randomised factorial trial assessing early oral   1989;80:410-414.
                        captopril, oral mononitrate, and intravenous magnesium sul-    104. Ohman EM, Armstrong PW, Christenson RH, et al. Cardiac
                        phate in 58,050 patients with suspected acute myocardial infarc-  troponin T levels for risk stratification in acute myocardial
                        tion. Lancet. 1995;345:669-685.                        ischemia. N Engl J Med. 1996;335:133-1341.
                     89. First International Study of Infarct Survival Collaborative     105. Lewis HD Jr, Davis JW, Archibald DG, et al. Protective effects
                        Group. Randomised trial of intravenous atenolol among 16 027   of aspirin against acute myocardial infarction and death in men
                        cases of suspected acute myocardial infarction: ISIS-1. Lancet.   with unstable angina. Results of a Veterans Administration
                        1986;2:57-66.                                          Cooperative Study. N Engl J Med. 1983;309:396-403.
                     90. TIMI Study Group. Comparison of invasive and conservative     106. Cairns JA, Gent M, Singer J, et al. Aspirin, sulfinpyrazone, or
                        strategies after treatment with intravenous tissue plasminogen   both in unstable angina. Results of a Canadian multicenter trial.
                        activator in acute myocardial infarction. Results of the throm-  N Engl J Med. 1985;313:1369-1375.
                        bolysis in myocardial infarction (TIMI) phase II trial. N Engl J
                        Med. 1989;320:618-627.                              107. Yusuf  S,  Zhao  F,  Mehta  SR,  Chrolavicius  S,  Tognoni  G,  Fox
                                                                               KK.  Effects  of  clopidogrel  in  addition to  aspirin in  patients
                     91. Chen ZM, Pan HC, Chen YP, et al. Early intravenous then oral   with acute coronary syndromes without ST-segment elevation.
                        metoprolol in 45,852 patients with acute myocardial infarc-  N Engl J Med. 2001;345:494-502.
                        tion: randomised placebo-controlled trial.  Lancet. 2005;366:
                        1622-1632.                                          108. Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment
                                                                               with clopidogrel and aspirin followed by long-term therapy in
                     92. MIAMI Trial Research Group. Metoprolol in acute myocardial   patients undergoing percutaneous coronary intervention: the
                        infarction (MIAMI). A randomised placebo-controlled interna-  PCI-CURE study. Lancet. 2001;358:527-533.
                        tional trial. Eur Heart J. 1985;6:199-226.          109. Steinhubl SR, Berger PB, Mann JT III, et  al. Early and sus-
                     93. The International Collaborative Study Group. Reduction of   tained dual oral antiplatelet therapy following percutaneous
                        infarct size with the early use of timolol in acute myocardial   coronary intervention: a randomized controlled trial.  JAMA.
                        infarction. N Engl J Med. 1984;310:9-15.               2002;288:2411-2420.
                     94. Dargie HJ. Effect of carvedilol on outcome after myocardial     110. CAPRIE Steering Committee. A randomised, blinded, trial of
                        infarction in patients with left-ventricular dysfunction: the   clopidogrel versus aspirin in patients at risk of ischaemic events
                        CAPRICORN randomised trial. Lancet. 2001;357:1385-1390.  (CAPRIE). Lancet. 1996;348:1329-1339.
                     95. CONSENSUS Trial Study Group. Effects of enalapril on mortal-    111. Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopi-
                        ity in severe congestive heart failure. Results of the Cooperative   dogrel in patients with acute coronary syndromes. N Engl J Med.
                        North Scandinavian Enalapril Survival Study (CONSENSUS).   2009;361:1045-1057.
                        N Engl J Med. 1987;316:1429-1435.                   112. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA
                     96. SOLVD Investigators. Effect of enalapril on survival in patients   2007 guidelines for the management of patients with unstable
                        with reduced left ventricular ejection fractions and congestive   angina/non ST-elevation myocardial infarction: a report of the
                        heart failure. N Engl J Med. 1991;325:293-302.         American College of Cardiology/American Heart Association
                     97. SOLVD Investigators. Effect of enalapril on mortality and   Task Force on Practice Guidelines.  J Am Coll Cardiol.
                        the development of heart failure in asymptomatic patients   2007;116:803-877.
                        with reduced left ventricular ejection fractions. N Engl J Med.     113. Theroux P, Ouimet H, McCans J, et al. Aspirin, heparin, or both
                        1992;327:685-691.                                      to treat acute unstable angina. N Engl J Med. 1988;319:1105-1111.








              Section03-O-ref.indd   4                                                                                   1/20/2015   7:10:23 AM
   519   520   521   522   523   524   525   526   527   528   529